Biopredictive:
Non-invasive liver diagnostic tests.

The goal of BioPredictive is the discovery and development of new non-invasive diagnostic tests which aim to improve the management of liver disease.

After FibroTest's launch in 2002, which has since turned out to be the reference in its field, BioPredictive is once again breaking new ground with the SteatoTest, the NashTest, the AshTest and the FibroMax.
www.biopredictive.com

PHARMXPAND AND PHARMXPANSION INC.
The PharmXpansion/ PharmXpand companies are specialized in the marketing and distribution of products in diagnostics, pharmaceutical and bioscience industry.

We help deliver breakthrough diagnostics, and innovative products to patients through targeted promotional activities and worldwide distribution partnerships.

CONTACT US
PharmXpand: North and South America contact@pharmxpand.com

PharmXpansion : Europe, Middle East and North Africa: contact@pharmxpansion.com

INTERESTED IN DISTRIBUTING OR PERFORMING THE TESTS?

Feel free to inquire at this email: contact@pharmxpansion.com